Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

OBN Co-Founds and Subscribes to EDCA

Published: Tuesday, February 05, 2013
Last Updated: Tuesday, February 05, 2013
Bookmark and Share
Company takes this step in support of its diagnostics member companies.

OBN has announced its co-founding and support of the European Diagnostic Clusters Alliance (EDCA). This significant step has been taken in support of OBN’s Diagnostic Member Companies.

OBN believes that the first European world class diagnostic cluster has now become a reality through the creation of the EDCA an international non-for-profit organization, headquartered in Brussels.

Through this Alliance, OBN will help to foster and develop collaborative networking between the other allied European diagnostic clusters in order to consolidate the competitiveness of their SMEs.

Access to non-EU markets (USA and Asia) for European medical diagnostic SMEs is also a key objective to the EDCA members.

OBN has been increasing its activity in support of SME diagnostics businesses in the UK in recent years, with last October’s very popular BioTuesday event “Meet with AstraZeneca's Head of Personalized Healthcare & Biomarkers and Biomarker company showcase.”

What does this mean for OBN diagnostics Members? They will gain access to sources of information on potential collaborators, join in grant applications for European funding and have the opportunity to network with European colleagues and potential partners.

EDCA members participated in OBN’s BioTrinity 2012, Europe’s premier biopartnering and investment conference and it is hoped that OBN will lead a party of OBN Diagnostics company members to the forthcoming Euromediag International Convention in Montpelier in July.

OBN’s involvement includes Advisory Board Member Bruce Savage as treasurer and lead contact.

Dr Jon Rees, CEO of OBN, said: “I am delighted that OBN is a member of the EDCA, this demonstrates our ongoing engagement with Medical Technology companies, membership of the EDCA will strengthen our offering to member companies and will give them opportunities to collaborate and partner with organizations throughout Europe and beyond. Redoubling our commitment to this sector, OBN is now planning towards a new medtech and diagnostics investing and partnering conference.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

OBN Strikes Up Partnership with BioCity
OBN appoints senior buyer for member companies.
Monday, November 18, 2013
OBN Supports Stem Cell Patentability Consortium Letter
Letter calls for patentability of products derived from pluripotent stem cells.
Wednesday, July 17, 2013
OBN Announces Changes to Board of Directors
Appointment of David Boal as Director of business development.
Thursday, January 24, 2013
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!